Your browser doesn't support javascript.
loading
Early human lung immune cell development and its role in epithelial cell fate.
Barnes, Josephine L; Yoshida, Masahiro; He, Peng; Worlock, Kaylee B; Lindeboom, Rik G H; Suo, Chenqu; Pett, J Patrick; Wilbrey-Clark, Anna; Dann, Emma; Mamanova, Lira; Richardson, Laura; Polanski, Krzysztof; Pennycuick, Adam; Allen-Hyttinen, Jessica; Herczeg, Iván T; Arzili, Romina; Hynds, Robert E; Teixeira, Vitor H; Haniffa, Muzlifah; Lim, Kyungtae; Sun, Dawei; Rawlins, Emma L; Oliver, Amanda J; Lyons, Paul A; Marioni, John C; Ruhrberg, Christiana; Tuong, Zewen Kelvin; Clatworthy, Menna R; Reading, James L; Janes, Sam M; Teichmann, Sarah A; Meyer, Kerstin B; Nikolic, Marko Z.
Afiliación
  • Barnes JL; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Yoshida M; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • He P; Division of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Worlock KB; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Lindeboom RGH; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK.
  • Suo C; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Pett JP; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Wilbrey-Clark A; Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Dann E; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Mamanova L; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Richardson L; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Polanski K; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Pennycuick A; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Allen-Hyttinen J; Enhanc3D Genomics Ltd, Cambridge, UK.
  • Herczeg IT; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Arzili R; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Hynds RE; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Teixeira VH; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Haniffa M; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Lim K; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Sun D; Epithelial Cell Biology in ENT Research (EpiCENTR) Group, Developmental Biology and Cancer Department, Great Ormond Street UCL Institute of Child Health, University College London, London, UK.
  • Rawlins EL; CRUK Lung Cancer Centre Of Excellence, UCL Cancer Institute, University College London, London, UK.
  • Oliver AJ; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Lyons PA; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Marioni JC; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Ruhrberg C; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Tuong ZK; Wellcome Trust/CRUK Gurdon Institute and Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
  • Clatworthy MR; Department of Life Sciences, Korea University, Seoul, Republic of Korea.
  • Reading JL; Wellcome Trust/CRUK Gurdon Institute and Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
  • Janes SM; Wellcome Trust/CRUK Gurdon Institute and Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
  • Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Meyer KB; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Nikolic MZ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Sci Immunol ; 8(90): eadf9988, 2023 Dec 15.
Article en En | MEDLINE | ID: mdl-38100545
ABSTRACT
Studies of human lung development have focused on epithelial and mesenchymal cell types and function, but much less is known about the developing lung immune cells, even though the airways are a major site of mucosal immunity after birth. An unanswered question is whether tissue-resident immune cells play a role in shaping the tissue as it develops in utero. Here, we profiled human embryonic and fetal lung immune cells using scRNA-seq, smFISH, and immunohistochemistry. At the embryonic stage, we observed an early wave of innate immune cells, including innate lymphoid cells, natural killer cells, myeloid cells, and lineage progenitors. By the canalicular stage, we detected naive T lymphocytes expressing high levels of cytotoxicity genes and the presence of mature B lymphocytes, including B-1 cells. Our analysis suggests that fetal lungs provide a niche for full B cell maturation. Given the presence and diversity of immune cells during development, we also investigated their possible effect on epithelial maturation. We found that IL-1ß drives epithelial progenitor exit from self-renewal and differentiation to basal cells in vitro. In vivo, IL-1ß-producing myeloid cells were found throughout the lung and adjacent to epithelial tips, suggesting that immune cells may direct human lung epithelial development.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunidad Innata / Pulmón Límite: Humans Idioma: En Revista: Sci Immunol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunidad Innata / Pulmón Límite: Humans Idioma: En Revista: Sci Immunol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
...